WELL Health Technologies Corp (WELL) Stock Forecast & Price Target

Compare

2,269 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

WELL Analyst Ratings

Strong Buy

6 Buy

0 Hold

0 Sell

Based on 6 analysts giving stock ratings to

WELL

Health Technologies Corp

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

WELL Stock 12 Month Forecast

Average Price Target

C$7.60

▲(85.37% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for WELL Health Technologies Corp in the last 3 months. The average price target is C$7.60 with a high forecast of C$9.00 and a low forecast of C$5.50. The average price target represents a 85.37% change from the last price of C$4.10.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"C$2","4":"C$4","6":"C$6","8":"C$8","10":"C$10"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$9.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$7.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$5.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,4,6,8,10],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.72,4.126153846153846,4.532307692307692,4.938461538461539,5.344615384615384,5.750769230769231,6.156923076923077,6.563076923076922,6.969230769230769,7.375384615384615,7.781538461538462,8.187692307692307,8.593846153846153,{"y":9,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.72,4.018461538461539,4.316923076923077,4.615384615384616,4.913846153846154,5.212307692307693,5.510769230769231,5.809230769230769,6.107692307692307,6.406153846153846,6.704615384615385,7.003076923076923,7.3015384615384615,{"y":7.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.72,3.856923076923077,3.993846153846154,4.130769230769231,4.2676923076923075,4.404615384615385,4.541538461538462,4.678461538461539,4.815384615384615,4.952307692307692,5.0892307692307694,5.226153846153846,5.363076923076923,{"y":5.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.04,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.86,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.93,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.73,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.33,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.96,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.02,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.06,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.63,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.68,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.32,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.25,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.72,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetC$9.00

Average Price TargetC$7.60

Lowest Price TargetC$5.50

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Justin Keywood

Stifel Nicolaus

C$9

Buy

119.51%

Upside

Reiterated

12/08/25

Stifel Nicolaus Remains a Buy on WELL Health Technologies Corp (WELL)

Erin Kyle

CIBC

C$5.5

Buy

34.15%

Upside

Upgraded

12/03/25

Well Health upgraded to Outperformer from Neutral at CIBCWell Health upgraded to Outperformer from Neutral at CIBC

Douglas Miehm

RBC Capital

C$7

Buy

70.73%

Upside

Reiterated

11/07/25

RBC Capital Reaffirms Their Buy Rating on WELL Health Technologies Corp (WELL)

Allen Klee

Maxim Group

C$8

Buy

95.12%

Upside

Reiterated

11/07/25

Strong Financial Performance and Strategic Initiatives Justify Buy Rating for WELL Health Technologies Corp

Michael W. Freeman

Raymond James

―

Buy

―

Reiterated

11/06/25

WELL Health Technologies Corp: Strong Q3 Performance and Strategic Growth Initiatives Justify Buy Rating

Gianluca Tucci

Haywood

C$8.5

Buy

107.32%

Upside

Reiterated

10/31/25

WELL Health announced that its technology subsidiary, WELLSTAR, has secured $62M in growth financing ahead of its planned spin-out and public listing, expected in 2026. The financing will fund organic growth, AI innovation, and targeted acquisitions as WELLSTAR positions itself as a pure-play healthcare SaaS provider. The transaction follows an earlier $50.4M round completed in late 2024 that funded two tuck-in acquisitions and the initial formation of WELLSTAR as a separate operating entity. Together, these financings equip WELLSTAR with a robust capital base to execute its expansion strategy ahead of its debut as an independent public company. This financing values WELLSTAR at approximately $535M, post-money.

Doug Taylor

Canaccord Genuity

C$7

Buy

70.73%

Upside

Reiterated

08/14/25

Canaccord Genuity Remains a Buy on WELL Health Technologies Corp (WELL)

David Kwan

TD Cowen

C$8.5→C$7.5

Buy

82.93%

Upside

Reiterated

04/16/25

TD Cowen Sticks to Its Buy Rating for WELL Health Technologies Corp (WELL)

Kevin Krishnaratne

Scotiabank

C$8→C$7

Buy

70.73%

Upside

Reiterated

04/16/25

we maintain our Sector Outperform rating, with our new target of $7.00 (was $8.00)

Gabriel Leung

Beacon

C$11.04→C$12.41

Buy

202.80%

Upside

Reiterated

12/12/24

WELL Health Technologies wins price target raise at BeaconLeung says there are many things to like about this development.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Justin Keywood

Stifel Nicolaus

C$9

Buy

119.51%

Upside

Reiterated

12/08/25

Stifel Nicolaus Remains a Buy on WELL Health Technologies Corp (WELL)

Erin Kyle

CIBC

C$5.5

Buy

34.15%

Upside

Upgraded

12/03/25

Well Health upgraded to Outperformer from Neutral at CIBCWell Health upgraded to Outperformer from Neutral at CIBC

Douglas Miehm

RBC Capital

C$7

Buy

70.73%

Upside

Reiterated

11/07/25

RBC Capital Reaffirms Their Buy Rating on WELL Health Technologies Corp (WELL)

Allen Klee

Maxim Group

C$8

Buy

95.12%

Upside

Reiterated

11/07/25

Strong Financial Performance and Strategic Initiatives Justify Buy Rating for WELL Health Technologies Corp

Michael W. Freeman

Raymond James

―

Buy

―

Reiterated

11/06/25

WELL Health Technologies Corp: Strong Q3 Performance and Strategic Growth Initiatives Justify Buy Rating

Gianluca Tucci

Haywood

C$8.5

Buy

107.32%

Upside

Reiterated

10/31/25

Doug Taylor

Canaccord Genuity

C$7

Buy

70.73%

Upside

Reiterated

08/14/25

Canaccord Genuity Remains a Buy on WELL Health Technologies Corp (WELL)

David Kwan

TD Cowen

C$8.5→C$7.5

Buy

82.93%

Upside

Reiterated

04/16/25

TD Cowen Sticks to Its Buy Rating for WELL Health Technologies Corp (WELL)

Kevin Krishnaratne

Scotiabank

C$8→C$7

Buy

70.73%

Upside

Reiterated

04/16/25

we maintain our Sector Outperform rating, with our new target of $7.00 (was $8.00)

Gabriel Leung

Beacon

C$11.04→C$12.41

Buy

202.80%

Upside

Reiterated

12/12/24

WELL Health Technologies wins price target raise at BeaconLeung says there are many things to like about this development.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering WELL Health Technologies Corp

1 Month

xxx

Success Rate

13/23 ratings generated profit

Average Return

+2.85%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 56.52% of your transactions generating a profit, with an average return of +2.85% per trade.

3 Months

xxx

Success Rate

14/21 ratings generated profit

Average Return

+17.64%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +17.64% per trade.

1 Year

David KwanTD Cowen

Success Rate

14/23 ratings generated profit

Average Return

+70.82%

reiterated a buy rating 8 months ago

Copying David Kwan's trades and holding each position for 1 Year would result in 60.87% of your transactions generating a profit, with an average return of +70.82% per trade.

2 Years

xxx

Success Rate

10/23 ratings generated profit

Average Return

+49.24%

reiterated a xxx

rating 8 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 43.48% of your transactions generating a profit, with an average return of +49.24% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WELL Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, WELL has received 13 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. WELL average Analyst price target in the past 3 months is 7.60.

Each month's total comprises the sum of three months' worth of ratings.

WELL Financial Forecast

WELL Earnings Forecast

Next quarter’s earnings estimate for WELL is C$0.10 with a range of C$0.06 to C$0.14. The previous quarter’s EPS was C$0.16. WELL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year WELL has Performed in-line its overall industry.

WELL Sales Forecast

Next quarter’s sales forecast for WELL is C$385.23M with a range of C$369.00M to C$395.37M. The previous quarter’s sales results were C$364.60M. WELL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year WELL has Performed in-line its overall industry.

WELL Stock Forecast FAQ

What is TSE:WELL’s average 12-month price target, according to analysts?

Based on analyst ratings, WELL Health Technologies Corp’s 12-month average price target is 7.60.

What is TSE:WELL’s upside potential, based on the analysts’ average price target?

WELL Health Technologies Corp has 85.37% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TSE:WELL a Buy, Sell or Hold?

WELL Health Technologies Corp has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.

What is WELL Health Technologies Corp’s price target?

The average price target for WELL Health Technologies Corp is 7.60. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is C$9.00 ,the lowest forecast is C$5.50. The average price target represents 85.37% Increase from the current price of C$4.1.

What do analysts say about WELL Health Technologies Corp?

WELL Health Technologies Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of TSE:WELL?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

WELL Health Technologies Corp (WELL) Stock Forecast & Price Target

WELL Analyst Ratings

WELL Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering WELL Health Technologies Corp

WELL Analyst Recommendation Trends

WELL Financial Forecast

WELL Earnings Forecast

WELL Sales Forecast

WELL Stock Forecast FAQ

Detailed List of Analyst Forecasts